Eat, Inject, Repeat

New Drugs could Spell an end to the world’s obesity epidemic

· The new class of drugs, called GLP-1 receptor agonists, seems actually to work. Semaglutide, developed by Novo Nordisk, a Danish pharmaceutical firm, has been shown in clinical trials to lead to weight loss of about 15%